1Siegel R, Ward E, Brawley O, et al. Cancer statistics,2011 : the impact of eliminating socioeconomic and racial dispari- ties on premature cancer deaths [ J ]. CA Cancer J Clin, 2011,61 (4) :212-236. 被引量：1
2Naldi I, Tarama M, Gherardini L, et al. Novel epigenetic target therapy for prostate cancer : a preclinical study [ J ]. PLoS 0ne,2014,9(5) :e98101. 被引量：1
4Kubista M, Andrade J M, Bengtsson M, et al. The real-time polymerase chain reaction [ J ]. Mol Aspects Med, 2006,27 (2/3) :95-125. 被引量：1
5Barletta J. Applications of real-time immuno-polymerase chain reaction (rt-IPCR) for the rapid diagnoses of viral antigens and pathologic proteins [ J ]. Mol Aspects Med, 2006,27 ( 2/3 ) :224-253. 被引量：1
6Ross J S, Sheehan C E, Fisher H A, et al. Correlation of pri- mary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer[ J ]. Clin Cancer Res,2003,9(17) :6357-6362. 被引量：1
7Chou J, Burke N A, Iwabu A, et al. Directional motility in- duced by epidermal growth factor requires Cdc42 [ J ]. Exp Cell Res,2003,287( 1 ) :47-56. 被引量：1
8Yoshiji H, Kuriyama S, Kawata M, et al. The angiotensin-I- converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis : possible role of the vascular endo- thelial growth factor [ J ]. Clin Cancer Res, 2001,7 (4) : 1073-1078. 被引量：1
9Rajasekaran S A, Anilkumar G, Oshima E, et al. A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen [ J ]. Mol Biol Cell. 2003,14(12) :4835-4845. 被引量：1
10Beckett M L, Cazares L H, Vlahou A, et al. Prostate-spe- cific membrane antigen levels in sera from healthy men and patients with benign prostate hyperplasia or prostate cancer[ J]. Clin Cancer Res, 1999,5 ( 12 ) :4034-4040. 被引量：1
5Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtractionand microarray. Cancer Res 2000; 60(6): 1677-1682 被引量：1
6Jiang Z, Woda BA, Rock KL, et al. P504S: a new moleculer marker for the detection of f prostatic cancer. Am J Surg Pathol 2001; 25(11): 1397-1404 被引量：1
7Rubin MA, Zhou M, Dhanasekaran SM, et al. Alpha- Methylacyl-CoA Racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287(13): 1662-1670 被引量：1
8Lczkowski KA, Jiang Z, Tretiakova M, et al. Prostate needle biopsies with suspicious (ASAP) diagnosis:80% resolved using P504S/AMACR and keration34E12 immunostaining. Mod Pathol 2003; 16: 154A 被引量：1
9Beach R, Gown AM, Peralta-Venturina MN, et al. P504S cal detection in 405 prostatic specimens including 376 18-gauge needle biopsies, Am J Surg Pathol 2002; 26(12): 1588-1596 被引量：1
10Kunju LP, Rubin MA, Shen R, et al. Comparison of monoclonal antibody (P504S) and polyclonal antibody to Alpha-met hylacyl CoA racemase in benign atypical and malignant prostate tissue. Mod Pathol 2003; 16: 158A 被引量：1
